| 000 | 00989 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513233257.0 | ||
| 264 | 0 | _c20010405 | |
| 008 | 200104s 0 0 eng d | ||
| 022 | _a1465-6566 | ||
| 024 | 7 |
_a10.1517/14656566.1.3.367 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKhare, M D | |
| 245 | 0 | 0 |
_aInfluenza. _h[electronic resource] |
| 260 |
_bExpert opinion on pharmacotherapy _cMar 2000 |
||
| 300 |
_a367-75 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfluenza, Human _xdrug therapy |
| 650 | 0 | 4 |
_aNeuraminidase _xantagonists & inhibitors |
| 700 | 1 | _aSharland, M | |
| 773 | 0 |
_tExpert opinion on pharmacotherapy _gvol. 1 _gno. 3 _gp. 367-75 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14656566.1.3.367 _zAvailable from publisher's website |
| 999 |
_c11186357 _d11186357 |
||